13D/13G Filings - Integrated Core Strategies (US) LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...4, 5, 6, 7, 8, ...18, 19, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-01-23
4:24 pm
Sale
2023-12-31 13G AngioDynamics, Inc.
ANGO
Integrated Core Strategies (US) LLC 1,835,777
4.600%
-219,470decrease
(-10.68%)
Filing
History
2024-01-23
4:20 pm
Sale
2023-12-31 13G Ebix, Inc.
EBIXQ
Integrated Core Strategies (US) LLC 245,507
0.800%
-1,376,628decrease
(-84.87%)
Filing
History
2024-01-22
4:04 pm
Sale
2023-12-31 13G Kezar Life Sciences, Inc.
KZR
Integrated Core Strategies (US) LLC 292,756
4.000%
-85,297decrease
(-22.56%)
Filing
History
2024-01-19
4:26 pm
Sale
2023-12-31 13G NextCure, Inc.
NXTC
Integrated Core Strategies (US) LLC 1,140,389
4.100%
-309,496decrease
(-21.35%)
Filing
History
2024-01-18
4:16 pm
Sale
2023-12-31 13G Emergent BioSolutions Inc.
EBS
Integrated Core Strategies (US) LLC 2,095,662
4.000%
-615,737decrease
(-22.71%)
Filing
History
2024-01-17
5:01 pm
Sale
2023-12-31 13G Esperion Therapeutics, Inc.
ESPR
Integrated Core Strategies (US) LLC 3,643,951
3.200%
-1,722,501decrease
(-32.10%)
Filing
History
2024-01-16
4:18 pm
Sale
2023-12-31 13G X4 Pharmaceuticals, Inc.
XFOR
Integrated Core Strategies (US) LLC 1,664,317
1.000%
-6,604,499decrease
(-79.87%)
Filing
History
2024-01-16
4:16 pm
Sale
2023-12-31 13G Motorcar Parts of America, Inc.
MPAA
Integrated Core Strategies (US) LLC 209,590
1.100%
-776,557decrease
(-78.75%)
Filing
History
2024-01-16
4:12 pm
Sale
2023-12-31 13G Inozyme Pharma, Inc.
INZY
Integrated Core Strategies (US) LLC 911,465
1.500%
-1,381,362decrease
(-60.25%)
Filing
History
2024-01-16
4:09 pm
Sale
2023-12-31 13G Designer Brands Inc.
DBI
Integrated Core Strategies (US) LLC 140,617
0.300%
-2,847,722decrease
(-95.29%)
Filing
History
2024-01-16
4:05 pm
Sale
2023-12-31 13G American Vanguard Corporation
AVD
Integrated Core Strategies (US) LLC 951,357
3.300%
-749,135decrease
(-44.05%)
Filing
History
2024-01-12
4:26 pm
Sale
2023-12-31 13G Viking Therapeutics, Inc.
VKTX
Integrated Core Strategies (US) LLC 403,556
0.400%
-4,425,644decrease
(-91.64%)
Filing
History
2024-01-12
4:16 pm
Sale
2023-12-31 13G scPharmaceuticals Inc.
SCPH
Integrated Core Strategies (US) LLC 356,873
1.000%
-1,365,966decrease
(-79.29%)
Filing
History
2024-01-12
4:12 pm
Sale
2023-12-31 13G The Joint Corp.
JYNT
Integrated Core Strategies (US) LLC 68,815
0.500%
-734,648decrease
(-91.44%)
Filing
History
2024-01-11
4:15 pm
Purchase
2024-01-05 13G Enanta Pharmaceuticals, Inc.
ENTA
Integrated Core Strategies (US) LLC 1,314,949
6.200%
290,273increase
(+28.33%)
Filing
History
2024-01-11
4:09 pm
Sale
2023-12-31 13G Gossamer Bio, Inc.
GOSS
Integrated Core Strategies (US) LLC 4,224,610
1.900%
-579,691decrease
(-12.07%)
Filing
History
2024-01-10
4:25 pm
Sale
2023-12-31 13G LendingTree, Inc.
TREE
Integrated Core Strategies (US) LLC 345,355
2.700%
-328,369decrease
(-48.74%)
Filing
History
2024-01-09
4:30 pm
Purchase
2024-01-04 13G Mobileye Global Inc.
MBLY
Integrated Core Strategies (US) LLC 5,876,403
6.200%
5,876,403increase
(New Position)
Filing
History
2024-01-09
4:26 pm
Sale
2023-12-31 13G iTeos Therapeutics, Inc.
ITOS
Integrated Core Strategies (US) LLC 967,402
2.700%
-1,123,431decrease
(-53.73%)
Filing
History
2024-01-05
4:12 pm
Sale
2023-12-31 13G Maravai LifeSciences Holdings, Inc.
MRVI
Integrated Core Strategies (US) LLC 6,007,149
4.500%
-968,778decrease
(-13.89%)
Filing
History
Goto Prev, 0, 1, ...4, 5, 6, 7, 8, ...18, 19, Next